NCT05803473Completed
DIAbetes TEam and Cgm in Managing Hospitalised Patients with Diabetes
In-hospital Diabetes Management by a Diabetes Team and Continuous Glucose Monitoring or Point of Care Glucose Testing (DIATEC): a Randomised Trial
Source: ClinicalTrials.gov · Last updated 26 Feb 2025
Brief summary (registry, in English)
This trial investigates the effects of continuous glucose monitoring (CGM) and an in-hospital diabetes team on in-hospital glycemic and clinical outcomes in patients with type 2 diabetes compared to standard glucose point-of-care (POC) testing and an in-hospital diabetes team.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 166 (actual)
- First submitted
- 14 Mar 2023
- Start date
- 11 Apr 2023
- Primary completion date
- 29 Mar 2024
- Lead sponsor
- Peter Kristensen
- Diseases
- Type 2 diabetes
- NCT number
- NCT05803473
What you commit to
- Study type: Interventional
- Participants enrolled: 166
- From 11 Apr 2023 to the primary completion date, 29 Mar 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Treated with hydroxyurea/hydroxycarbamid
- Nutritional therapy (continuous enteral or parenteral feeding)
- Systemic glucocorticoid treatment with prednisone equivalent dose \>5 mg/day
Other illness
- Clinically relevant pancreatic disease
- Known hypersensitivity to the band-aid of the CGM Dexcom G6 sensor.
Lab values
- Estimated glomerular filtration rate (eGFR) \<15 mL/min/1.73 m2
Other
- Patients on out-hospital basal insulin with duration of action \> 24 hours (Toujeo or Tresiba)
- Expected to require admission to the intensive-care unit
- Anasarca (severe and general edema)
- Dialysis
Who the study is looking for
- A documented history of T2DM prior to inclusion
- Age ≥ 18 years old
- Willingness and ability to comply with the clinical investigation plan
- Ability to communicate in Danish with the trial personnel
- An expected length of hospital stay for at least two days after enrolment
- If subject with childbearing potential (subject \< 50 years old); willing to have a urine pregnancy test performed and/or to use a highly effective method of contraception (i.e., birth control implant, intrauterine device, birth control shot, or sterilisation).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Copenhagen University Hospital - Herlev-Gentofte (Steno Diabetes Center Copenhagen) Coordinator of this site? Confirm its status | Herlev | Denmark | Unknown status |
| Copenhagen University Hospital - North Zealand Coordinator of this site? Confirm its status | Hillerød | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.